Serum Institute of India writes to PMO recommending reforms in drug regulatory system
THD NewsDesk, New Delhi: Serum Institute of India (SII); the world's largest vaccine manufacturer has written to the Prime Minister's ...
THD NewsDesk, New Delhi: Serum Institute of India (SII); the world's largest vaccine manufacturer has written to the Prime Minister's ...
EU reported cases of liver injury, following which DCGI ordered state drug controllers to recall ulipristal tablets from the market. ...
NPPA has cited problems in approving of the FDCs, saying it can cause over-medication It says that it might lead ...
THD NewsDesk, NEW DELHI: The DCGI has authorized the commercial launch of 'Feluda', the Tata CRISPR (Clustered Regularly Interspaced Short ...
A daily dose of news, views, opinions, and actionable information from the global healthcare industry. Our newsletter is available for a limited audience. If you are interested to write or contribute to this portal then please get in touch.
© 2025 - The Healthcare Daily